Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein.

Incubation in vitro of recombinant wild-type murine p53 protein with S-nitroso-N-acetyl-DL-penicillamine [a nitric oxide (NO)-releasing compound] has resulted in a change of p53 conformation and also in a significant decrease of its specific DNA binding activity. Similarly, upon treatment with S-nitroso-N-acetyl-DL-penicillamine (2-5 mM) or S-nitroso-glutathione (1-2 mM), human breast cancer cells (MCF-7), which express wild-type p53, rapidly accumulated p53 protein in the nuclei. This p53 protein, however, possessed a significantly decreased activity of specific DNA binding. On the other hand, lower concentrations of NO donors (0.25-0.5 mM) stimulated p53 accumulation as well as its DNA binding activity. These results suggest that excess NO produced in inflamed tissues could play a role in carcinogenesis by impairing the tumor suppressor function of p53.

[1]  Y. Henry,et al.  EPR characterization of molecular targets for NO· in mammalian cells , 1997 .

[2]  James B. Mitchell,et al.  The effect of various nitric oxide-donor agents on hydrogen peroxide-mediated toxicity: a direct correlation between nitric oxide formation and protection. , 1996, Archives of biochemistry and biophysics.

[3]  Jen-kun Lin,et al.  Induction of p53 and p21/WAF1/CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells , 1996, Molecular carcinogenesis.

[4]  C. Harris,et al.  Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[5]  H. Ohshima,et al.  Formation of 8‐nitroguanine in DNA treated with peroxynitrite in vitro and its rapid removal from DNA by depurination , 1995, FEBS letters.

[6]  V. Wahn,et al.  Nitric oxide induces apoptosis in mouse thymocytes. , 1995, Journal of immunology.

[7]  Richard Graham Knowles,et al.  Nitric oxide synthase activity in human breast cancer. , 1995, British Journal of Cancer.

[8]  C. Cross,et al.  Tyrosine modification by reactive nitrogen species: a closer look. , 1995, Archives of biochemistry and biophysics.

[9]  J. Stamler,et al.  Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. , 1995, Gut.

[10]  K. Aldape,et al.  Expression of nitric oxide synthase in human central nervous system tumors. , 1995, Cancer research.

[11]  B. Brüne,et al.  p53 expression in nitric oxide‐induced apoptosis , 1994, FEBS letters.

[12]  I. Charles,et al.  Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation. , 1994, British Journal of Cancer.

[13]  G. Wahl,et al.  DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. , 1994, Genes & development.

[14]  J. Stamler,et al.  Redox signaling: Nitrosylation and related target interactions of nitric oxide , 1994, Cell.

[15]  Carl Nathan,et al.  Nitric oxide synthases: Roles, tolls, and controls , 1994, Cell.

[16]  C. Harris,et al.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. , 1994, Cancer research.

[17]  P. Jeffrey,et al.  Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. , 1994, Science.

[18]  Richard Graham Knowles,et al.  Nitric oxide synthase activity in human gynecological cancer. , 1994, Cancer research.

[19]  H. Bartsch,et al.  Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. , 1994, Mutation research.

[20]  D. Bishop,et al.  p53 protein detected by immunohistochemical staining is not always mutant. , 1993, Disease markers.

[21]  P. Hainaut,et al.  Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. , 1993, Cancer research.

[22]  C. Hawkey,et al.  Nitric oxide synthase activity in ulcerative colitis and Crohn's disease , 1993, The Lancet.

[23]  C. Purdie,et al.  Thymocyte apoptosis induced by p53-dependent and independent pathways , 1993, Nature.

[24]  J Milner,et al.  A structural role for metal ions in the "wild-type" conformation of the tumor suppressor protein p53. , 1993, Cancer research.

[25]  B. Vogelstein,et al.  A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia , 1992, Cell.

[26]  J. Shay,et al.  A transcriptionally active DNA-binding site for human p53 protein complexes , 1992, Molecular and cellular biology.

[27]  S. Tannenbaum,et al.  DNA damage and mutation in human cells exposed to nitric oxide in vitro. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[28]  T. Cebula,et al.  DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. , 1991, Science.

[29]  B. Vogelstein,et al.  Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication , 1991, Cell.

[30]  J. Milner,et al.  Tumor suppressor p53: analysis of wild-type and mutant p53 complexes , 1991, Molecular and cellular biology.

[31]  M. Marletta.  Mammalian synthesis of nitrite, nitrate, nitric oxide, and N-nitrosating agents. , 1988, Chemical research in toxicology.

[32]  P. Hainaut,et al.  Analysis of p53 quaternary structure in relation to sequence-specific DNA binding. , 1994, Oncogene.

[33]  J. Bartek,et al.  Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli. , 1992, Journal of cell science.

[34]  K. Appel,et al.  Nitrogen dioxide induces DNA single-strand breaks in cultured Chinese hamster cells. , 1990, Carcinogenesis.